Cite
Loureiro JB, Ribeiro R, Nazareth N, et al. Mutant p53 reactivator SLMP53-2 hinders ultraviolet B radiation-induced skin carcinogenesis. Pharmacol Res. 2021;175:106026doi: 10.1016/j.phrs.2021.106026.
Loureiro, J. B., Ribeiro, R., Nazareth, N., Ferreira, T., Lopes, E. A., Gama, A., Machuqueiro, M., Alves, M. G., Marabini, L., Oliveira, P. A., Santos, M. M. M., & Saraiva, L. (2021). Mutant p53 reactivator SLMP53-2 hinders ultraviolet B radiation-induced skin carcinogenesis. Pharmacological research, 175106026. https://doi.org/10.1016/j.phrs.2021.106026
Loureiro, Joana B, et al. "Mutant p53 reactivator SLMP53-2 hinders ultraviolet B radiation-induced skin carcinogenesis." Pharmacological research vol. 175 (2021): 106026. doi: https://doi.org/10.1016/j.phrs.2021.106026
Loureiro JB, Ribeiro R, Nazareth N, Ferreira T, Lopes EA, Gama A, Machuqueiro M, Alves MG, Marabini L, Oliveira PA, Santos MMM, Saraiva L. Mutant p53 reactivator SLMP53-2 hinders ultraviolet B radiation-induced skin carcinogenesis. Pharmacol Res. 2021 Dec 08;175:106026. doi: 10.1016/j.phrs.2021.106026. Epub 2021 Dec 08. PMID: 34890775.
Copy
Download .nbib